Treace Medical Concepts (TMCI) Inventory Average (2021 - 2026)

Treace Medical Concepts (TMCI) has reported Inventory Average for 6 consecutive years, with $38.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory Average fell 5.51% year-over-year to $38.0 million; the trailing twelve-month figure through Jun 2026 stood at $38.0 million (down 5.51% YoY), and the FY2025 full-year result was $37.6 million, up 9.91% from the prior year.
• Inventory Average improved to $38.0 million in Q2 2026 per TMCI's latest filing, from $36.2 million in the prior quarter.
• Across five years, Inventory Average topped out at $42.4 million in Q3 2024 and bottomed at $10.8 million in Q1 2022.
• Historically, Inventory Average has averaged $30.4 million across 5 years, with a median of $34.4 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Inventory Average jumped 100.25% in 2023, then fell 6.53% in 2025.
• Over 5 years, Inventory Average stood at $18.1 million in 2022, then jumped by 62.1% to $29.3 million in 2023, then surged by 41.51% to $41.4 million in 2024, then dropped by 6.53% to $38.7 million in 2025, then declined by 2.0% to $38.0 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $38.0 million, $36.2 million, and $38.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.